OC06_03 An International Pilot Study of the Barriers and Facilitators to the Use of Evidence Based Drugs in the Secondary Prevention of Cardiovascular Diseases

Rates of evidence-based cardiovascular medication (EBM) use globally are sub-optimal, and are poorest in low-income countries. An understanding of the barriers and facilitators of EBM use among countries of different incomes may allow innovative approaches to be developed to optimize cardiovascular disease (CVD) prevention.

Source: CVD Prevention and Control - May 31, 2016 Category: Global & Universal Authors: S. Khandelwal, V. Peck, L. Nambiar, M. Saxena, D. Leong, A. Banerjee, J.P. Werba, J.R.F. Neto, M. Moniruzzaman, K.C. Quinto, CARDIOMAPPS group Tags: Oral Abstract Source Type: research